网站主页>>>项目整合精选>>>项目整合精选>>>新产品编号:1065195

新产品编号:1065195

Chemical Name: 5-Bromo-N-[1-ethyl-4-methylperhydro-1,4-diazepin-6(R)-yl]-2-methoxy-6-(methylamino)pyridine-3-carboxamide
项目整合开发状态: Preclinical
项目研究机构: Dainippon Pharmaceutical (Originator)
合成路线:Esterification of 2,6-difluoronicotinic acid (I) with methanol and sulfuric acid afforded methyl ester (II).This was treated with methylamine in DMF at 5 C to give a 2:1 mixture of the desired 6-methylaminonicotinate (III) and its regioisomer (IV),which were separated by column chromatography.Reaction of (III) with potassium methoxide generated from methanol and potassium tert-butoxide yielded methyl ether (V).Then,bromination with N-bromosuccinimide in DMF gave bromoester (VI),which was subsequently hydrolyzed with aqueous NaOH to provide acid (VII).Finally,the target amide was prepared by condensation of acid (VII) with the chiral amine (VIII) in the presence of carbonyldiimidazole.
📌 参考资料/链接:
参考文献标题:Synthesis of N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)nicotinamides and their affinities for 5-HT3 and dopamine D2 receptors
文献作者:Hirokawa,Y.; Yoshida,N.; Kato,S.
参考来源:Bioorg Med Chem Lett 1998,8(12),1551